iShares Core S&P 500 ETF vs Health Care Select Sector SPDR Fund — how do they compare? iShares Core S&P 500 ETF trades at $781.97 (market cap $897.20B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: iShares Core S&P 500 ETF is far larger — about 20.6× Health Care Select Sector SPDR Fund's market cap, and iShares Core S&P 500 ETF is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares Core S&P 500 ETF for 46 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| IVV | XLV | |
|---|---|---|
Market Cap | $897.20B | $43.48B |
Volume | 4,580,672 | 11,121,431 |
Sector | Broad Market / Factor | — |
52-Week High | $782.58 | $175.68 |
52-Week Low | $634.93 | $141.95 |
Typical Hold Time | 46 Days | 100 Days |
Signals from Pluang's Aura AI — not financial advice
IVV, tracking the S&P 500, trades at $777.38, down 0.41% on the day, with a bullish technical signal from moving averages and neutral oscillators. Support lies at $775 and resistance at $780. Recent news highlights strong 2026 earnings growth expectations of 35% but a projected slowdown to 15% in 2027, with valuation debates ongoing amid index concentration risks.
The outlook remains cautiously optimistic given bullish technicals and Wall Street's long-term growth projections, but risks include profit growth deceleration, high market concentration, and interest rate sensitivity. IVV offers broad market exposure, yet investors should weigh slowing corporate earnings against historical bullish seasonal trends.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
IVV tracks the performance of the S&P 500 Index, offering low-cost exposure to 500 of the largest US companies. It is a cornerstone for long-term investors seeking broad growth in the US stock market.
Read more on IVV →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →